$ARIA Recent Headlines Apple closes lower; B. of A. rises

New Post Public Reply Private Reply Replies (0) Message Board

Jan 12, 2014 at 10:07 PM

$ARIA Recent Headlines

Apple closes lower; B. of A. rises on analyst call 4:15 p.m. Jan. 2, 2014 - Wallace Witkowski
Apple gains on China Mobile deal; homebuilders rally 3:33 p.m. Dec. 23, 2013 - Wallace Witkowski
Suspension is lifted for Ariad's leukemia drug 6:33 a.m. Dec. 23, 2013 - MarketWatch.com
J.C. Penney and more of the year's most profitable shorts 3:23 p.m. Dec. 9, 2013 - blogs.marketwatch.com
Hewlett-Packard, a cyclical green light and why silver is in trouble 8:50 a.m. Nov. 26, 2013 - Shawn Langlois
Ariad takes another pounding after leukemia treatment is pulled 12:14 p.m. Oct. 31, 2013 - Russ Britt
H-P has best day in four months on upbeat outlook 3:34 p.m. Oct. 9, 2013 - Sue Chang
Ariad plummets 70% after drug test patients have serious clotting issues 10:38 a.m. Oct. 9, 2013 - Russ Britt
FDA places partial hold on Ariad's Iclusig trials 7:16 a.m. Oct. 9, 2013 - MarketWatch.com
Dan Loeb makes bet on Disney 7:06 p.m. Aug. 14, 2013 - David Benoit
Onyx share surge lifts several boats in biotech harbor, including ETFs 10:33 a.m. July 1, 2013 - Russ Britt
SAC Capital Advisors likes this pharma stock 3:24 p.m. April 18, 2013 - Insider Monkey
Ariad Pharma up 6% to $20.09 10:35 a.m. Dec. 17, 2012 - Steve Gelsi
FDA OKs Iclusig to treat rare types of leukemia 1:06 p.m. Dec. 14, 2012 - MarketWatch.com
Stocks: Investors play the waiting game 8:53 a.m. Dec. 11, 2012 - The Trading Deck
12 biotech stocks hit 52-week highs 2:43 p.m. July 27, 2012 - Val Brickates Kennedy
Three rules for short selling 12:01 a.m. Feb. 2, 2012 - The Trading Deck
Stocks to watch Wednesday: C.R. Bard, Papa John’s 6:52 a.m. Dec. 21, 2011 - MarketWatch
Don't be a fan when investing 8:26 a.m. Dec. 20, 2011 - The Trading Deck
Drug stocks move higher in late trading 2:26 p.m. March 24, 2011 - Val Brickates Kennedy

Biotech Stock Mailbag: NeoStem, MannKind, Inovio 6:00 a.m. Jan. 10, 2014 - TheStreet.com
Some Stock Ideas For January 2014 9:28 a.m. Jan. 8, 2014 - Seeking Alpha
Ariad Pharmaceuticals (ARIA): Today's Featured Drugs Laggard 5:01 p.m. Jan. 7, 2014 - TheStreet.com
ARIAD to Present at JPM Conference - Analyst Blog 6:00 p.m. Jan. 6, 2014 - Zacks.com
UPDATE: Ariad Pharmaceuticals Downgraded by Citigroup 10:42 a.m. Jan. 6, 2014 - benzinga.com
Citi negative on Sarepta, Ariad for 2014, shares slide 8:21 a.m. Jan. 6, 2014 - Seeking Alpha
Top Analyst Downgrades, Stocks to Sell: Apple, Twitter, First Solar and More 7:53 a.m. Jan. 6, 2014 - 247WallSt.com
Benzinga's Top #PreMarket Losers 7:19 a.m. Jan. 6, 2014 - benzinga.com
A Strange Mix of Action 4:44 p.m. Jan. 3, 2014 - RealMoney.com
Patience and Prudence 10:39 a.m. Jan. 3, 2014 - RealMoney.com
Biotech Stock Mailbag: Inovio, Chelsea, Exelixis, Ariad, ImmunoCellular 8:00 a.m. Jan. 3, 2014 - TheStreet.com
Ariad rallies, company to present at conference 1:37 p.m. Jan. 2, 2014 - Seeking Alpha
Benzinga's Top #PreMarket Gainers 7:12 a.m. Jan. 2, 2014 - benzinga.com
ARIAD to Present at JP Morgan Healthcare Conference on Tuesday, January 14 at 6:00 PM ET 6:39 a.m. Jan. 2, 2014 - benzinga.com
Can The Uptrend Continue for Ariad Pharmaceuticals, Inc. (ARIA)? - Tale of the Tape 8:41 a.m. Dec. 31, 2013 - Zacks.com
Mid-Day Market Update: US Markets Turn Lower; Twitter Shares Fall On Analyst Downgrade 12:46 p.m. Dec. 27, 2013 - benzinga.com
Mid-Morning Market Update: Markets Mostly Higher; Textron To Acquire Beechcraft For $1.4B 10:19 a.m. Dec. 27, 2013 - benzinga.com
Ariad Revenue Boosted by Iclusig 12:45 a.m. Dec. 27, 2013 - Barrons.com
Ariad Pharmaceuticals (ARIA): Today's Featured Drugs Laggard 5:01 p.m. Dec. 26, 2013 - TheStreet.com
Update on ARIAD's Iclusig - Analyst Blog 4:45 p.m. Dec. 26, 2013 - Zacks.com

Notable Buzzers: Ariad Pharmaceuticals, Twitter Inc, Facebook Inc, Qihoo 360 Technology 11:10 a.m. Jan. 8, 2014 - ACCESSWIRE
Conferences, Completed Acquisitions, and Stock Price Movements - Research Report on Ariad, Salix, Molina, Mednax, and Merrimack 8:00 a.m. Jan. 7, 2014 - PR Newswire
Morning Buzzers: Apple Inc, Plug Power Inc, Ariad Pharmaceuticals, Biodel Inc 10:01 a.m. Jan. 3, 2014 - ACCESSWIRE
ARIAD to Present at the 32nd Annual J.P. Morgan Healthcare Conference 7:34 a.m. Jan. 2, 2014 - BusinessWire
FDA Approvals, Stock Price Movements, and Acquisitions - Research Report on ARIAD, Gentium, Salix Pharmaceuticals, NPS Pharmaceuticals, and MEDNAX 8:00 a.m. Dec. 25, 2013 - PR Newswire
Insider Catalyst Report: Ariad Pharmaceuticals, Advanced Micro Devices, Petroleo Brasileiro Petrobras, Endeavor IP Inc 10:32 a.m. Dec. 23, 2013 - ACCESSWIRE
Stock Price Updates, Executive Appointments, Acquisitions, Orphan Drug Designations, and Preclinical Developments - Research Report on Ariad, Halozyme, DepoMed, Omeros, and BioCryst 8:00 a.m. Dec. 23, 2013 - PR Newswire
Technical Research on Equities: Ariad Pharma, MannKind, Galena Biopharma, and Novavax 8:00 a.m. Dec. 23, 2013 - PR Newswire
Bullish Trend Analysis: Ariad Pharmaceuticals, Federal Home Loan Mortgage Corp, NQ Mobile Inc, Micron Technology 11:02 a.m. Dec. 20, 2013 - ACCESSWIRE
ARIAD Announces U.S. Resumption of Marketing and Commercial Distribution of Iclusig (ponatinib) in Refractory Philadelphia-Positive Leukemias 10:10 a.m. Dec. 20, 2013 - BusinessWire
Sector PE Trend, Return On Asset, and Consensus Earnings Forecast for Facebook, Ford Motor, Ariad Pharmaceuticals, Rite Aid, Sirius XM, and Tesla Motors 9:00 a.m. Dec. 20, 2013 - PR Newswire
Traders Buzz: Oracle Corporation, General Electric Company, Ariad Pharmaceuticals, Vertex Pharmaceuticals Incorporated 10:40 a.m. Dec. 19, 2013 - ACCESSWIRE
Published Data, Stock Price Movements, and FDA Approvals - Research Report on Johnson & Johnson, Ariad Pharmaceuticals, PerkinElmer, BD, and Sanofi 8:00 a.m. Dec. 13, 2013 - PR Newswire
Morning Buzz: Facebook Inc, BlackBerry Ltd, Ariad Pharmaceuticals, Nokia Corporation 11:19 a.m. Dec. 12, 2013 - ACCESSWIRE
Stocks Of The Day: Alpha Natural Resources, Apple Inc, Ariad Pharmaceuticals, Verizon Communications 10:40 a.m. Dec. 9, 2013 - ACCESSWIRE
Faruqi & Faruqi, LLP Files Class Action Lawsuit Against ARIAD Pharmaceuticals, Inc. (ARIA) 8:00 p.m. Dec. 6, 2013 - PR Newswire
UPCOMING DEADLINE: Levi & Korsinsky, LLP Announces Class Action Against ARIAD Pharmaceuticals, Inc. and Its Board of Directors and a Lead Plaintiff Deadline of December 9, 2013 -- ARIA 6:11 p.m. Dec. 5, 2013 - PR Newswire
Blue Chip Stock News: Ariad Pharmaceuticals, Citigroup Inc, Arena Pharmaceuticals, Market Vectors Gold Miners 9:45 a.m. Dec. 5, 2013 - ACCESSWIRE
Stock Price Movements, Campaigns, New Clinical Studies, and Approvals- Research Report on Actavis, Ariad Pharmaceuticals, DaVita, Celldex, and WellCare 8:00 a.m. Dec. 5, 2013 - PR Newswire
MolecularMD Announces Presentations at Upcoming American Society of Hematology Annual Meeting 7:00 a.m. Dec. 5, 2013 - Marketwire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

SAGA Metals Strikes Potential with Wolverine Drilling Program

Drilling for Treasure in Labrador's Rich Earth Hey, ever felt that gritty thrill in your bones? That's what I imagine SAGA Metals must be feeling right now. When you're out there punching holes into Mother Earth hoping to hit pay dirt, and every single one of those holes hits something juicy—trust me, that's like hitting the jackpot before even knowing the lottery...

Webull Hit with Class Action: Investors Eye Recovery

Webull's Tangled Web: An Investment Shocker It seems Webull Corporation (NASDAQ: BULL) hasn't been playing it straight with its investors, and now it's caught up in a web of legal trouble. If you've got skin in the game, especially if you nabbed Webull securities between April 2025 and October 2026, this class action lawsuit isn't just a blip—it's your wake-up call. The...

Watchtower Labs: New Era of AI in Military Ops

Big Moves in Military Planning Alright, folks, here's the skinny on something that's bound to shake up the military sector: Watchtower Labs has kicked the door open after its stealthy beginnings with a hefty $35 million in seed funding. Investors like Shield Capital, Conviction, and Founders Fund are throwing their weight behind this AI-powered venture that's poised to...

CHERY Unveils New SUVs: A Family-Centric Approach

Expanding the Family Focus at CHERY Brand Night When I saw the splash that CHERY Auto made at their Brand Night in Wuhu, Anhui, I had to take a moment. It wasn't just about unveiling the All-New TIGGO7 and the TIGGOX7, but a whole philosophy geared towards families and their ever-shifting needs. Now, they didn't skimp on the fanfare—inviting families from places like...

Sustainability Conference Gathers Leaders in Shanghai

Shanghai's Moment as a Global Sustainability Hub Shanghai's not pulling any punches, hosting a heavyweight gathering of global leaders, thinkers, and innovators with their eyes set on the prize: a sustainable future. As the 2026 Sustainability Global Leaders Conference unfolds in the bustling Huangpu district from October 20 to 22, more than 300 top-tier minds will churn...

Pearson Targets 2026 Growth with Strategic Moves

Pearson's Q3 Performance: Crunch Time Checking the rearview mirror at Pearson's nine-month journey into 2026, it's quite the sight. Q3 revved up with a 6% growth spurt, aligning neatly with market expectations. Ain't that a relief in today's rocky terrain of education and assessment? Holding a tight rein, they're on course to meet the mid-single digit revenue growth they...

Husqvarna Faces EU's Anti-Dumping Probe on Mowers

Investigating Robotic Mower Imports Some news for Husqvarna Group today, where the European Commission dropped a disclosure that’s sure to keep the execs on their toes. Yeah, we’re talking about that anti-dumping investigation, where the EU’s been eyeing imports of robotic mowers from China. Now, this isn’t the final bell—just another step in an ongoing...

GALY Expands Cocoa Operations US, UAE in 2026

The Evolution of GALY's Cocoa Strategy Alright, let's talk chocolate—a staple that somehow turned into high-tech business news. GALY is stepping up its game big time, pushing its cultured cocoa front into both the U.S. and the UAE. If you ask me, it's a smart move, adding some resilience to the cocoa supply chain that otherwise dances on the whims of Mother Nature. GALY...

First Horizon Faces $24M Fraud Allegation Showdown

First Horizon Under the High-Beam Out here in the high-stakes world of finance, knowing when to move and when to wait is the name of the game. But what happens when your trusted financial partner might just be nodding off at the wheel? That’s exactly the conundrum boiling in the Sunshine State, with First Horizon Bank at the center of a $24 million storm. Allegations...

EU Prioritizes Tech Sovereignty at UnitedXR Europe

Technological sovereignty isn’t just some highbrow jargon tossed around at seminars. It’s all about who gets to steer the ship in the realm of immersive tech. With EU Tech Chief Henna Virkkunen stepping up to the plate at UnitedXR Europe, a swarm of minds are descending on Brussels from December 7 to 9, with Virkkunen's session slated for December 8. You can bet your...